Large-scale testing (Phase 3)Ended earlyNCT01546571What this trial is testingStudy of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma PatientsWho this might be right forMelanoma Polynoma LLC 504
Early research (Phase 1)Study completedNCT00515983What this trial is testingVaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma CellsWho this might be right forMelanoma José Mordoh, M.D., Ph.D. 16
Not applicableEnded earlyNCT02336763What this trial is testingRadiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver MetastasesWho this might be right forIris MelanomaMedium/Large Size Posterior Uveal MelanomaStage IIA Uveal Melanoma+4 more Jonsson Comprehensive Cancer Center 2
Large-scale testing (Phase 3)Active Not RecruitingNCT04099251What this trial is testingEffectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 790
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableLooking for participantsNCT03116412What this trial is testingTrial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk MelanomaWho this might be right forMalignant Melanoma Uppsala University 1,300
Large-scale testing (Phase 3)Ended earlyNCT04901988What this trial is testingCirculating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTIONWho this might be right forMelanoma (Skin)Melanoma, Stage II The Christie NHS Foundation Trust 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT02068586What this trial is testingSunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal MelanomaWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+9 more Sidney Kimmel Cancer Center at Thomas Jefferson University 210
Testing effectiveness (Phase 2)Ended earlyNCT05234437What this trial is testingA Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c MelanomaWho this might be right forMelanoma QBiotics Group Limited 1
Early research (Phase 1)Study completedNCT01989559What this trial is testingBooster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By SurgeryWho this might be right forRecurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more National Cancer Institute (NCI) 30
Not applicableStudy completedNCT03154190What this trial is testingHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerWho this might be right forAcute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more Stanford University 128
Testing effectiveness (Phase 2)Study completedNCT00938223What this trial is testingEvaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced MelanomaWho this might be right forMelanoma Craig L Slingluff, Jr 51
Early research (Phase 1)Study completedNCT00680589What this trial is testingPatients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune ResponseWho this might be right forMelanoma Memorial Sloan Kettering Cancer Center 12
Very early researchStudy completedNCT02320305What this trial is testingMART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by SurgeryWho this might be right forStage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin Melanoma+4 more Mayo Clinic 23
Testing effectiveness (Phase 2)Ended earlyNCT01978236What this trial is testingDabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and MetabolitesWho this might be right forMelanoma and Brain Metastases GlaxoSmithKline 6
Testing effectiveness (Phase 2)Ended earlyNCT00184067What this trial is testingContinuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With MelanomaWho this might be right forMelanoma University of Southern California 23
Not applicableStudy completedNCT03028948What this trial is testingInteractive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With MelanomaWho this might be right forStage 0 Skin MelanomaStage I Skin MelanomaStage IA Skin Melanoma+9 more Rutgers, The State University of New Jersey 485
Very early researchStudy completedNCT00580060What this trial is testingInjection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And ImmunityWho this might be right forMelanoma Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06265285What this trial is testingComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramWho this might be right forAdvanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more Mayo Clinic 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05608291What this trial is testingA Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With SurgeryWho this might be right forMelanoma Regeneron Pharmaceuticals 1,564